The mechanisms that control the adrenal secretion of aldosterone are not completely understood. Recent evidence suggests that the release of renin from the kidneys with subsequent stimulation of aldosterone secretion by angiotensin may play a major role in the regulation of sodium balance (1) (2) (3) (4) (5) (6) (7) . Furthermore, the secretion of renin has been linked to changes in sodium balance (8) (9) (10) .
Through its action on the kidneys aldosterone not only influences sodium excretion but also plays an important role in the regulation of potassium balance. Since potassium balance may change independently of sodium balance, the possibility must be recognized that changes in potassium balance could also play an important role in the regulation of aldosterone secretion. Previous studies have shown that potassium administration can stimulate aldosterone secretion in the dog (11, 12) , and balance studies in man have indicated that changes in potassium intake exert slight effects on urinary excretion of aldosterone (13) (14) (15) (16) (17) .
For this reason and because situations exist in which hypersecretion of aldosterone occurs without clinical evidence to suggest marked angiotensinemia the present study was undertaken to define in man, under conditions in which sodium intake was rigidly controlled, the character of the aldosterone response to changes in potassium balance.
The data demonstrate that potassium salt administration stimulates aldosterone secretion in normal man. Depending upon the state of sodium balance or the disease state present, the magnitude of the stimulus to aldosterone secretion produced by potassium administration can equal or exceed that produced by an infusion of angiotensin II.
Methods
The 23 normal volunteers and the 23 patients who participated in this study were admitted to the metabolism ward where they were given a constant daily diet of known electrolyte content. The subjects received the control diet for at least 4 to 6 days before a study was started.
Patients with elevated blood pressures but no evidence of cardiac or retinal complications were classified as primary (benign essential) hypertension (6) . Patients with high blood pressures and evidence of renal or retinal complications were classified as advanced hypertension (4) . Criteria for retinal complications were the presence of hemorrhages or exudates. Renal complications were defined as the presence of proteinuria (2+) or a blood urea nitrogen greater than 30 mg per 100 ml. Patients with unequivocal papilledema were classified as malignant hypertension. Hypertensive patients with renal arterial stenosis were verified by aortography or at operation (7) . Each of the three hypertensive patients with primary aldosteronism had oversecretion of aldosterone that was corrected by removal of an adrenal tumor. No patient with a blood urea nitrogen greater than 45 mg per 100 ml was studied.
The patient with renal tubular acidosis was a 33-yearold female with a clinical syndrome (18) characterized by inability to lower urinary pH below 6.3, hypokalemia, nephrocalcinosis, and a normal level of blood urea nitrogen. Balance data suggested impairment of renal sodium conservation. The other patient with nephropathy was an 11-year-old Negro boy with clinical features similar to patients with the syndrome of primary juxtaglomerular complex hyperplasia (19 (20, 21) . Venous blood for measurement of plasma electrolytes was drawn each morning 60 to 90 minutes after an oral K+ load. Serial determinations throughout the day in eight patients revealed that in most subjects peak blood levels occurred at this time. Aldosterone secretion rates were measured by an isotope dilution technique in which 7 or 1-2 tritium-labeled aldosterone 2 that had been checked for purity and stability was utilized. One to 2 /Ac of the labeled hormone dissolved in 5 to 10 ml of 10% ethanol was injected intravenously at the beginning of each study. The subsequent 24-hour urine was incubated at pH 1 for 24 hours. The aldosterone liberated by this procedure was identified by paper chromatography, eluted, and then acetylated with acetic anhydride-"C to form aldosterone diacetate. After further chromato-graphic purification on a paper and on a Celite column the 3H to`C ratio of the purified sample was determined, and from this the 24-hour secretion rate of aldosterone was calculated utilizing standard isotope dilution equations. The final values were corrected for isotope displacement (22) . Twenty-four-hour excretion rates of the acid labile conjugate of aldosterone were also measured by the same principle and analytic procedures. For the latter determination, however, a known amount of the labeled hormone was added to the urine after hydrolysis but before extraction. By these methods normal subjects on unrestricted diets may exhibit secretion rates ranging from 75 to 300 ug per day and excretion rates from 7 to 30 jug per 24 hours, with the variation depending to a great extent on the sodium intake.
Results
The results of 69 metabolic balance studies (of from 5 to 30 days in duration) carried out on 46 subjects are presented in Figures 1 to 7 and Tables  I to III. Potassium administration to normal subjects Normal sodium diet. In Table I (Figure 2 ). Both the secretion and excretion rates of aldosterone returned to control values a few days after potassium supplements were stopped.
Low sodium diet. In contrast, the administration of similar amounts of potassium (mean, 150 mEq of K+ orally per 24 hours) for 4 to 6 days produced much larger increases in the aldosterone secretion and excretion rates of normal subjects after sodium depletion. Sodium depletion was achieved by a low salt diet alone in six studies and by a low salt diet combined with administration of saliuretic diuretics (four studies). As illustrated by two representative studies presented in detail (Table I, Figure 1 ) potassium administration usually caused neither significant natriuresis nor loss of weight. Plasma concentrations of potassium increased, but they remained in the same range (3.5 to 5.5 mEq per L) as in the studies of subjects who received a normal sodium intake.
In ten studies of salt-depleted normal subjects the mean increment in aldosterone secretion induced by potassium feeding was 841 Mg per 24 hours ( Figure 2 potassium concentration was + 0.7 mEq per L; mean weight change was + 0.51 kg. The greatest increments in aldosterone secretion that were induced by potassium occurred in four subjects in whom the degree of sodium depletion had been increased by the administration of saliuretic diuretics 4 to 6 days before onset of the study.
Potassium depletion in normal subjects
Normal sodium diet. In two normal subjects ( Figure 3 , Table II ) the administration of a supplemented synthetic diet containing 86 to 102 mEq of sodium and 3 to 5 mEq of potassium per day was followed by significant reductions in the adrenal secretion rate of aldosterone (-52 and -202 Mug per 24 hours). During this period potassium balance was negative (cumulative K+ balances: -166 and -122 mEq K+), and a moderate hypokalemia (plasma [K+], 3.5 and 3.7 mEq per L) ensued. Both subjects maintained a normal sodium balance.
Low sodium diet. In two other normal subjects ( Figure 3 , Table II ) administration of an artificial diet deficient both in sodium and potassium resulted in negative sodium and potassium balances (cumulative K+ balances: -196 and -124 mEq K+) and modest falls in plasma potassium concentration (plasma [K+], 3.3 and 3.2 mEq per L). The secretion rate of aldosterone increased somewhat in the subjects (+ 162 and + 213 MAg per 24 hours) ; however, the normal rise in aldosterone secretion usually observed after sodium restriction (23) was considerably blunted. In one of the subjects ( Figure 4 ) the administration of oral Ki after 6 to 7 days induced a sharp rise in aldosterone secretion (+ 310 ug per 24 hours) to the expected high levels, but only a slight rise (+ 0.8 mEq per L) in plasma [K+] .
Diuretic-induced potassium depletion. In 11 studies diuretic agents known to increase potassium excretion were administered to normal subjects for periods of from 5 to 26 days. In five studies 80 mEq or more of dietary NaCl was given in the daily diet; in six studies the diet contained only 14 to 17 mEq NaCl daily. Two representative studies of one subject appear in Figure 4 . Both ethacrynic acid and hydrochlorothiazide induced natriuresis, diuresis, and loss of weight; mean weight loss for the group was 2.4 kg. Both induced significant renal K4 loss (e.g., Figure 4 , cumulative K+ balances: -442 and -515 mEq K+) and hypokalemia (mean fall in 11 studies, 1.3 mEq per L; range, 0.5 to 2.3 mEq per L). However, in contrast to the effects of dietary Na4 and K4 depletion, aldosterone secretion rates rose to very high levels after administration of these diuretics, despite much greater potassium losses and greater degrees of hypokalemia than had been produced by dietary deprivation (Figure 4) (Table III) were qualitatively similar but smaller than those observed in normal subjects (Figure 2 (Table  III) .
The elevated aldosterone secretion rates of two patients with malignant hypertension increased more than twofold in response to potassium (+ 1,297 and + 1,500 jug per 24 hours). Both of these patients received a normal sodium intake during the study. A detailed balance of one (LU) who progressed from advanced to malignant hypertension appears in Figure 5 . In this patient a negative sodium balance did not accompany the large increment in aldosterone secretion induced by potassium. A greater rise in aldosterone out- 
FIG. 4. EFFECT OF DIURETICS ON ELECTROLYTE BALANCE AND ALDOSTERONE SECRE-TION.
Both ethacrynic acid and chlorothiazide produced weight loss and increased urinary excretion of sodium, potassium, and chloride. Despite negative potassium balances and hypokalemia in both studies aldosterone secretion and excretion rose to very high levels. put in response to potassium administration was observed after the disease process had progressed from the advanced to the accelerated phase.
Aldosterone-secreting adenomas. In three patients in whom hypertension and hypokalemia were caused by the presence of aldosterone-secreting tumors, the administration of potassium produced very large rises in aldosterone production (mean, + In contrast to normal subjects, these patients when maintained on a normal sodium intake exhibited striking increases in aldosterone secretion in response to potassium administration. The phenomenon occurred without significant changes in sodium balance. Plasma potassium levels were increased but did not exceed the normal range. per 24 hours. In the other patient with nephropathy sodium deprivation combined with potassium administration caused an enormous rise in the aldosterone secretion rate to values over 6, 500 ,ug per 24 hours ( Figure 6 ).
Discussion
The data demonstrate that potassium administration stimulates, and potassium depletion retards, aldosterone secretion in man. The findings are in harmony with earlier work in the dog (11, 16, 24, 25) and with the reports that potassium increases the excretion of a urinary metabolite of aldosterone in man (13) (14) (15) (16) (17) .
The present study also points up three factors that can operate to amplify adrenal responsiveness to potassium administration. These are 1) the state of sodium balance, 2) the presence of an illdefined disturbance of renal function (that may have activated the renin-angiotensin system) as observed in the patients with renal arterial stenosis, advanced hypertensive disease, and renal tubular disorders, and 3) the presence of aldosterone-secreting adrenal tumors.
Potassium administration to normal subjects produced only modest increments in aldosterone secretion (mean, + 107 /.tg per day); the administration of similar amounts after sodium depletion caused marked increments in aldosterone secretion (mean, +841 ,ug per day). Qualitatively similar but smaller response patterns were observed in patients with essential hypertension. This modifying influence of the state of sodium balance on adrenal cortical responsiveness to potassium is opposite to that observed with infu- (Tables I and III, Figures 1,  5 , and 6) potassium administration caused large increases in aldosterone secretion, whereas plasma potassium levels remained within the normal range. Also, the induced increments in potassium concentration associated with the large increases in aldosterone secretion (salt-depleted normals, ad-876 vanced hypertension, renal tubular disease) were no greater than the increments observed in the normal subjects who exhibited a minimal hormonal response to potassium salts. Lastly, the marked hypokalemia of diuretic therapy exerted less retarding influence on aldosterone secretion than the milder hypokalemia of dietary depletion. Therefore, it seems possible that the tissue uptake of potassium somewhere in the body (perhaps the adrenal glomerulosa cells), rather than the absolute level of plasma potassium, is the more critical determinant of the aldosterone response to alterations in potassium balance.
A relationship derived from the present data may improve our understanding of how potassium ions affect the adrenal cortex. The magnitude of the response of the adrenal glomerulosa to potassium observed in 50 studies of normal and hypertensive subjects was found to be directly related to the prior rate of production of aldosterone (Figure 7) , that is, larger increments in aldosterone secretion were induced by potassium when the adrenal gland was already hyperactive. This relationship held whether adrenal overactivity resulted from an autonomous adenoma or from presumed extra-adrenal stimulation via renin (sodium depletion, diuretics, hypertensive-renal disease).
Thus, all of our results might best be explained by postulating that 1) adrenal cellular accumulation of potassium in response to a positive K+ balance directly increases aldosterone secretion, and 2) the effect of a given amount of potassium upon adrenal production of aldosterone is directly related to the pre-existing level of adrenal stimulation by other factors. The other known factors that might operate to condition the effect of potassium on the adrenal are the level of circulating renin and angiotensin as affected by changes in sodium balance or as altered by renal dysfunction in the patients with hypertension or renal diseases, conceivably ACTH release in acute stress situations, and primary or autonomous adrenal hyperactivity as encountered in patients with adrenal tumors.
These findings complicate current concepts of the control of aldosterone and electrolyte homeostasis. They imply that there may be a double cycle feedback system whereby primary control of aldosterone secretion by the renin-angiotensin system responsive to changes in sodium balance or renal blood flow or both is supplemented and complemented by another mechanism in which a direct stimulatory effect of potassium upon the adrenal gland is conditioned by the existing level of adrenal secretory activity. Such a dual mechanism would provide a finely adjustable homeostatic defense of plasma K+ concentration in the event of renal failure or in the face of any large or sudden change in potassium balance.
Summary
Dietary potassium supplements (107 to 160 mEq daily for 4 to 6 days) stimulated aldosterone secretion in 23 of 25 studies of normal subjects and in 24 of 26 studies of patients with hypertensive or renal tubular disease. Dietary or diuretic-induced potassium depletion reduced aldosterone secretion if simultaneous sodium depletion was avoided but did not prevent an aldosterone rise in response to renal sodium loss. The influence of potassium depletion on aldosterone secretion could not be exclusively related to plasma potassium levels because the more severe hypokalemia of diuretic therapy was accompanied by an increased, and the milder hypokalemia of dietary depletion by a reduced, aldosterone secretion.
The effect of potassium balance on aldosterone secretion could not be explained adequately by induced changes in sodium balance and activation of the renin-angiotensin system or even by observed alterations in plasma potassium levels. It may therefore result from a more subtle consequence of altered potassium balance, perhaps involving direct adrenal cellular uptake of potassium.
The aldosterone secretory response to potassium administration was enhanced by four-to tenfold or more 1) after sodium depletion in normal subjects or patients with essential hypertension, 2) in patients receiving normal sodium diets who had renal arterial stenosis, advanced or malignant hypertension, or renal tubular disease characterized by sodium wasting, and 3) in patients with primary aldosteronism. In these circumstances, the magnitude of the aldosterone response to potassium was equal to or greater than that described for angiotensin. In normal subjects and in hypertensive patients with primary or secondary aldosteronism, the aldosterone response to potassium was directly related to the pre-existing rate of aldosterone secretion, regardless of whether the latter resulted from an autonomous tumor or from extra-adrenal stimulation, presumably via renin.
This conditioning of the stimulatory influence of potassium upon aldosterone by the prior level of adrenal activity suggests that the regulation of aldosterone is normally controlled by a complementary interrelationship between direct adenotrophic effects of potassium and activity of the renin-angiotensin system.
